1. Home
  2. CTKB vs PAXS Comparison

CTKB vs PAXS Comparison

Compare CTKB & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.32

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Logo PIMCO Access Income Fund of Beneficial Interest

PAXS

PIMCO Access Income Fund of Beneficial Interest

HOLD

Current Price

$13.81

Market Cap

665.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTKB
PAXS
Founded
1990
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
652.1M
665.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CTKB
PAXS
Price
$4.32
$13.81
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$5.63
N/A
AVG Volume (30 Days)
725.9K
229.0K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$193,015,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$7.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.67
N/A
52 Week Low
$2.37
$13.63
52 Week High
$6.18
$16.56

Technical Indicators

Market Signals
Indicator
CTKB
PAXS
Relative Strength Index (RSI) 44.29 27.80
Support Level $4.00 N/A
Resistance Level $4.51 $16.07
Average True Range (ATR) 0.18 0.30
MACD 0.04 -0.05
Stochastic Oscillator 43.13 3.19

Price Performance

Historical Comparison
CTKB
PAXS

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About PAXS PIMCO Access Income Fund of Beneficial Interest

PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.

Share on Social Networks: